Related Experiment Video
Updated: Jul 13, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
m6A Writer METTL3-Mediated lncRNA LINC01125 Prevents the Malignancy of Papillary Thyroid Cancer
Tianyou He1, Hailiang Xia1, Baojie Chen1
1Department of General Surgery, Wuhan Third Hospital (Tongren Hospital of Wuhan University), Wuhan 430060, Hubei, China.
Background:
Long non-coding RNA (lncRNA) LINC01125 is an anti-tumor factor in a variety of tumors, and regulates cancer cell function. However, its function and mechanism of N6-methyladenosine (m6A) modification in papillary thyroid cancer (PTC) tumorigenesis remain unclear.
Aims:
This study aimed to reveal the function and m6A modification of LINC01125 in PTC tumorigenesis.
Methods:
The LINC01125 and methyltransferase-like 3 (METTL3) levels in PTC cells and tissues was assessed by qRT-PCR. The binding relationship among LINC01125 and METTL3 was determined by MeRIP, Pearson, bioinformatics, and RNA stabilization analysis. Transwell assays were performed to confirm the changes of PTC cell migration and invasion. Cell proliferation was revealed by CCK-8 as well as colony formation assays.
Results:
Low expression of LINC01125 and METTL3 was identified in PTC. LINC01125 was a downstream target of METTL3-mediated m6A modification and was stably upregulated via METTL3. Cell invasion, migration, viability, and colony formation levels were decreased when LINC01125 or METTL3 was upregulated. Inhibition of LINC01125 had the opposite impact, promoting cell proliferation and metastasis, and reversing METTL3 overexpression-resulted cell malignancy suppression.
Conclusions:
Overall, this study proved that the m6A modification of LINC01125 was mediated by METTL3 and LINC01125 inhibited cell invasion, migration and proliferation, thereby suppressing the development of PTC. This points to the LINC01125-m6A-METTL3 axis as a possible prospective target for future treatment of PTC.
Insights
Methyltransferase-like 3 (METTL3) mediates N6-methyladenosine (m6A) modification of long non-coding RNA LINC01125, inhibiting papillary thyroid cancer (PTC) cell invasion, migration, and proliferation. This axis presents a potential therapeutic target for PTC.
Area of Science:
- Molecular Oncology
- Epigenetics
- RNA Biology
Background:
- Long non-coding RNA (lncRNA) LINC01125 exhibits anti-tumor properties in various cancers.
- The role and N6-methyladenosine (m6A) modification mechanism of LINC01125 in papillary thyroid cancer (PTC) tumorigenesis are not well understood.
Purpose of the Study:
- To elucidate the function of LINC01125 in PTC.
- To investigate the m6A modification of LINC01125 and its regulatory mechanism in PTC tumorigenesis.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to assess LINC01125 and METTL3 expression.
- MeRIP, Pearson correlation, bioinformatics, and RNA stabilization assays to determine LINC01125-METTL3 interactions.
- Transwell, CCK-8, and colony formation assays to evaluate PTC cell migration, invasion, and proliferation.
Main Results:
- Reduced expression of LINC01125 and METTL3 was observed in PTC tissues.
- LINC01125 is a downstream target of METTL3-mediated m6A modification and is stabilized by METTL3.
- Upregulation of LINC01125 or METTL3 suppressed PTC cell invasion, migration, viability, and colony formation.
Conclusions:
- METTL3-mediated m6A modification of LINC01125 inhibits PTC cell progression.
- The LINC01125-m6A-METTL3 axis acts as a tumor suppressor in PTC.
- This axis represents a potential therapeutic target for PTC treatment.
More Related Videos
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
11:11Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
Published on: April 25, 2018
Related Concept Videos
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
MicroRNAs
Non-LTR Retrotransposons
The Nucleolus
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...